p21 is required for atRA-mediated growth inhibition of MEPM cells, which involves RAR

Zengli Yu1, Wenjie Li, Quanjun Lu

  • 1Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou 450001, China. zly@zzu.edu.cn

Insights

All-trans retinoic acid (atRA) inhibits mouse embryonic palatal mesenchymal cell growth by increasing p21 levels, causing cell cycle arrest. This study identifies p21 as a key mediator in atRA

Area of Science:

  • Developmental Biology
  • Cell Biology
  • Molecular Biology

Background:

  • All-trans retinoic acid (atRA), a vitamin A metabolite, is crucial for embryonic development.
  • Tight control of atRA's spatial and temporal distribution is essential.
  • Excessive atRA can cause growth inhibition and p21 accumulation in MEPM cells.

Purpose of the Study:

  • To identify the mediator of all-trans retinoic acid-induced growth inhibition in mouse embryonic palatal mesenchymal cells.
  • To elucidate the role of p21 in atRA-mediated cellular responses.
  • To investigate the involvement of RAR in the atRA signaling pathway.

Main Methods:

  • Cell cycle analysis (flow cytometry) to assess G1 arrest and DNA fragmentation.
  • Western blotting to evaluate protein levels (p21, cyclin D1) and Rb phosphorylation.
  • Luciferase reporter assays to measure p21 and RARE promoter activity.
  • siRNA-mediated gene silencing to assess the necessity of p21 and RAR.
  • Chromatin immunoprecipitation (ChIP) to confirm RAR binding to the p21 promoter.

Main Results:

  • atRA induced G1 cell cycle arrest and DNA fragmentation in MEPM cells.
  • atRA treatment increased p21 protein levels and decreased cyclin D1 and Rb phosphorylation.
  • p21 is required for atRA-induced growth inhibition, as confirmed by siRNA knockdown.
  • RAR is involved in atRA-induced p21 expression, with RAR binding to the p21 promoter.

Conclusions:

  • p21 is the primary mediator of all-trans retinoic acid-induced growth inhibition in mouse embryonic palatal mesenchymal cells.
  • RAR signaling plays a significant role in regulating p21 expression and mediating the cellular effects of atRA.
  • These findings highlight a critical molecular mechanism governing embryonic development and cellular growth control by vitamin A metabolites.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...